Home/Filings/4/0001213900-20-028837
4//SEC Filing

CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP 4

Accession 0001213900-20-028837

CIK 0001158780other

Filed

Sep 28, 8:00 PM ET

Accepted

Sep 29, 4:05 PM ET

Size

5.5 KB

Accession

0001213900-20-028837

Insider Transaction Report

Form 4
Period: 2020-09-28
Transactions
  • Purchase

    Common Stock

    2020-09-28$9.49/sh+13,189$125,1643,788,460 total
Footnotes (1)
  • [F1]The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from approximately $9.47 to $9.50 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

Issuer

PLURISTEM THERAPEUTICS INC

CIK 0001158780

Entity typeother

Related Parties

1
  • filerCIK 0001810117

Filing Metadata

Form type
4
Filed
Sep 28, 8:00 PM ET
Accepted
Sep 29, 4:05 PM ET
Size
5.5 KB